Bank of America
LUMO

Bank of America’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bank of America’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,800
Closed -$6.97K – 8521
2024
Q3 		$6.97K Hold
1,800
– – ﹤0.01% 6956
2024
Q2 		$4.18K Hold
1,800
– – ﹤0.01% 7046
2024
Q1 		$5.08K Hold
1,800
– – ﹤0.01% 7000
2023
Q4 		$5.72K Hold
1,800
– – ﹤0.01% 6991
2023
Q3 		$5.94K Hold
1,800
– – ﹤0.01% 6956
2023
Q2 		$5.94K Hold
1,800
– – ﹤0.01% 6956
2023
Q1 		$5.96K Buy
1,800
+1,788
+14,900% +$6.26K ﹤0.01% 7030
2022
Q4 		$44 Buy
+12
New +$78 ﹤0.01% 7826
2022
Q1 		– Sell
-10
Closed – – 8885
2021
Q4 		$0 Buy
+10
New +$84 ﹤0.01% 8753
2021
Q3 		– Sell
-19
Closed – – 8466
2021
Q2 		$0 Buy
19
+6
+46% +$67 ﹤0.01% 8164
2021
Q1 		$0 Sell
13
-5,962
-100% -$100K ﹤0.01% 7865
2020
Q4 		$213K Sell
5,975
-2,210
-27% -$38.1K ﹤0.01% 5558
2020
Q3 		$113K Buy
8,185
+20
+0.2% +$299 ﹤0.01% 5628
2020
Q2 		$135K Hold
8,165
– – ﹤0.01% 5514
2020
Q1 		$69K Hold
8,165
– – ﹤0.01% 5720
2019
Q4 		$186K Sell
8,165
-36
-0.4% -$514 ﹤0.01% 5679
2019
Q3 		$117K Sell
8,201
-2,816
-26% -$41.3K ﹤0.01% 5971
2019
Q2 		$147K Sell
11,017
-11,290
-51% -$171K ﹤0.01% 5806
2019
Q1 		$387K Buy
22,307
+12,410
+125% +$185K ﹤0.01% 5175
2018
Q4 		$135K Sell
9,897
-855
-8% -$15.1K ﹤0.01% 5756
2018
Q3 		$231K Sell
10,752
-1,823
-14% -$55.4K ﹤0.01% 5412
2018
Q2 		$539K Sell
12,575
-14,077
-53% -$645K ﹤0.01% 4872
2018
Q1 		$1.74M Buy
26,652
+23,142
+659% +$1.64M ﹤0.01% 3986
2017
Q4 		$256K Buy
3,510
+2,495
+246% +$206K ﹤0.01% 5298
2017
Q3 		$93K Buy
1,015
+338
+50% +$25.9K ﹤0.01% 5706
2017
Q2 		$44K Sell
677
-2,869
-81% -$355K ﹤0.01% 5925
2017
Q1 		$769K Buy
3,546
+2,778
+362% +$397K ﹤0.01% 4605
2016
Q4 		$71K Buy
768
+504
+191% +$56.8K ﹤0.01% 5773
2016
Q3 		$36K Sell
264
-1,119
-81% -$111K ﹤0.01% 5867
2016
Q2 		$140K Buy
1,383
+1,113
+412% +$138K ﹤0.01% 5381
2016
Q1 		$45K Sell
270
-814
-75% -$165K ﹤0.01% 5826
2015
Q4 		$355K Buy
1,084
+885
+445% +$288K ﹤0.01% 5023
2015
Q3 		$64K Sell
199
-1,868
-90% -$821K ﹤0.01% 5853
2015
Q2 		$823K Buy
2,067
+1,152
+126% +$490K ﹤0.01% 4275
2015
Q1 		$451K Buy
915
+226
+33% +$87.6K ﹤0.01% 4390
2014
Q4 		$247K Buy
689
+612
+795% +$182K ﹤0.01% 5203
2014
Q3 		$15K Sell
77
-98
-56% -$21.5K ﹤0.01% 7183
2014
Q2 		$42K Sell
175
-257
-59% -$52.3K ﹤0.01% 6782
2014
Q1 		$111K Buy
432
+247
+134% +$75.5K ﹤0.01% 5917
2013
Q4 		$37K Buy
185
+65
+54% +$11.6K ﹤0.01% 6735
2013
Q3 		$20K Sell
120
-638
-84% -$103K ﹤0.01% 6892
2013
Q2 		$134K Buy
+758
New +$107K ﹤0.01% 5970

Bank of America's LUMO Position: Q4 2024 in Review

Bank of America sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 1,800 shares — an estimated $6.97K sold.

Bank of America first reported a position in LUMO in Q2 2013 and held it in 42 quarters. The position peaked at $1.74M in Q1 2018. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • Bank of America reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Bank of America sold 1,800 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $6.97K.
  • Bank of America first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
  • Bank of America's Lumos Pharma, Inc. Common Stock position peaked at $1.74M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Bank of America's 13F filing for Q4 2024, filed 14 Feb 2025.